Public Profile

Unipharm, Inc.

Unipharm, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various regions. Founded in 1995, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded medications. Unipharm's core offerings include a diverse range of pharmaceutical products, with a focus on injectables, oral solids, and topical formulations. What sets Unipharm apart is its commitment to innovation and quality, ensuring that all products meet stringent regulatory standards. With a strong market position, Unipharm has achieved significant milestones, including numerous FDA approvals and partnerships that enhance its product portfolio. The company continues to strive for excellence, making it a trusted name in the healthcare sector.

DitchCarbon Score

How does Unipharm, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Unipharm, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Unipharm, Inc.'s reported carbon emissions

Unipharm, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives related to climate commitments. Without specific emissions figures or defined goals, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, Unipharm's future commitments and strategies will be essential in understanding its role in reducing greenhouse gas emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Unipharm, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Unipharm, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Unipharm, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Worldline

FR
Financial intermediation services, except insurance and pension funding services (65)
Updated about 15 hours ago

Vitabiotics Ltd.

GB
Pharmaceutical Preparation Manufacturing
Updated about 22 hours ago

Bayer Australia Limited

AU
Pharmaceutical Preparation Manufacturing
Updated about 22 hours ago

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated about 15 hours ago

Bayer Pharma AG

DE
Pharmaceutical Preparation Manufacturing
Updated about 22 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers